TEVA Trademark

Trademark Overview

On Tuesday, January 7, 2020, a trademark application was filed for TEVA with the United States Patent and Trademark Office. The USPTO has given the TEVA trademark a serial number of 88749354. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by Teva Pharmaceutical Industries Limited. The TEVA trademark is filed in the Chemical Products category with the following description:

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals
teva

General Information

Serial Number88749354
Word MarkTEVA
Filing DateTuesday, January 7, 2020
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6342788
Registration DateTuesday, May 4, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements

Goods and ServicesBulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals
Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of THE WORD "TEVA" IN LOWER CASE LETTERS WITH THE "V" IN THE SHAPE OF TWO LEAVES.
Translation of Words in MarkThe English translation of the word "TEVA" in the mark is "NATURE".

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, January 10, 2020
Primary Code001
First Use Anywhere DateWednesday, February 28, 2018
First Use In Commerce DateWednesday, February 28, 2018

Trademark Owner History

Party NameTeva Pharmaceutical Industries Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTeva Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTeva Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Friday, January 10, 2020NEW APPLICATION ENTERED
Friday, January 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 11, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, January 24, 2020ASSIGNED TO EXAMINER
Wednesday, January 29, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 29, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, January 29, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 29, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, January 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 8, 2020ASSIGNED TO LIE
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 27, 2020ASSIGNED TO EXAMINER
Thursday, September 10, 2020TEAS STATEMENT OF USE RECEIVED
Friday, September 25, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 10, 2020USE AMENDMENT FILED
Monday, September 28, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, October 26, 2020SU - NON-FINAL ACTION - WRITTEN
Monday, October 26, 2020NON-FINAL ACTION E-MAILED
Monday, October 26, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 2, 2020ASSIGNED TO LIE
Thursday, December 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 23, 2020SU - FINAL REFUSAL - WRITTEN
Wednesday, December 23, 2020FINAL REFUSAL E-MAILED
Wednesday, December 23, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 12, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 12, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 10, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 15, 2021ASSIGNED TO LIE
Monday, March 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 26, 2021ASSIGNED TO EXAMINER
Friday, March 26, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 27, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 30, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, February 4, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 4, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 4, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 4, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 4, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

teva chemicals manufacture pharmaceuticals preparations chemical fine pharmaceutical bulk